-
Photovoltaic 24
-
Wind energy 6
-
Other renewable energy (nuclear, geothermal, etc.) 22
-
Grid/power transmission 23
-
Energy storage 31
-
Hydrogen energy 10
-
Lithium batteries 48
-
Electric vehicles 45
-
Low-carbon buildings and construction 7
-
Agriculture 11
-
Low-carbon consumer goods 6
-
New materials 22
-
Industrial manufacturing 7
-
Green transportation 22
-
CCUS 2
-
Digital technology for carbon accounting and consulting 22
-
Bio-Tech 2
-
Circular economy 31
All investors
114 institutional investors
Content Filter
-
Photovoltaic 24
-
Wind energy 6
-
Other renewable energy (nuclear, geothermal, etc.) 22
-
Grid/power transmission 23
-
Energy storage 31
-
Hydrogen energy 10
-
Lithium batteries 48
-
Electric vehicles 45
-
Low-carbon buildings and construction 7
-
Agriculture 11
-
Low-carbon consumer goods 6
-
New materials 22
-
Industrial manufacturing 7
-
Green transportation 22
-
CCUS 2
-
Digital technology for carbon accounting and consulting 22
-
Bio-Tech 2
-
Circular economy 31
-
Frees Fund
- Investments: 312
- Funds: 14
- Shanghai
-
Low-carbon consumer goods
Frees Fund is committed to making future-oriented investment, so it has become the first-round institutional investor of many forward-looking enterprises with original innovation ability. Consumption and TMT, high technology and biomedicine are the three major investment directions of Frees Fund. Frees Fund has invested in more than 150 innovative enterprises, covering lifestyle, culture and entertainment, finance, intelligent manufacturing, artificial intelligence, biotechnology and new drug research and development, new energy and new materials, and so on. Frees' portfolio not only includes Three Squirrels, 360 DigiTech, Uber Global, Unity and other listed companies, but also many innovative enterprises with high growth, including Qingtao Development, Xtaipi, Patpat, Coyote Bio, Robot Phoenix, Saturnbird Coffee, Pyrotech Therapeutics and so on.
-
Qiming VC
- Investments: 671
- Funds: 26
- Shanghai
-
Low-carbon consumer goods
Qiming Venture Partners is a top-tier VC firm with outstanding reputation. With our exceptional investment performances, we have been widely recognized by investors from around the world. We have a reputation for being entrepreneur friendly.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.4 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages. Many of our portfolio companies are today’s most influential firms in their respective sectors, including Xiaomi , Meituan, Bilibili, Zhihu, Roborock, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, Schrödinger, APT Medical, New Horizon Health, Venus MedTech, Sanyou Medical, AmoyDx， Berry Genomics, SinocellTech, Yuanxin Technology, dMed-Clinipace, Belief BioMed, WeRide, Biren Technology and UBTech among many others.
-
Nio Capital
- Investments: 75
- Funds: 6
- Ningbo, Zhejiang Province
-
Low-carbon consumer goods
Founded in 2016, NIO Capital is a professional investment institution deeply involved in the industry, focusing on the industrial changes brought about by low-carbon and digital technology and model innovation, and ESG sustainable investment in new energy, automobile and hard technology. Its investment cases include CATL, Ronbay Technology, United Winner Laser, Momenta, Inceptio Technology, Pony AI, Innovusion, Black Sesame Technologies, etc. NIO Capital has a compound team with profound industrial background and professional investment management capabilities, as well as an excellent ecological circle resource network in the industry. We have a deep understanding of entrepreneurs, a deep insight into the investment field, provide multi-dimensional and deep-level support for the invested enterprises, and help great ideas grow into great enterprises and become their dream builder and companion.
-
K2VC
- Investments: 688
- Funds: 11
- Beijing
-
Low-carbon consumer goods
Founded in 2010, K2VC focuses on early investment in the new economy, and is committed to promoting technological progress, business model innovation and the evolution of people's lifestyles. Our subsidiaries cover investment in the Internet, consumption, medicine, and other fields. We have invested in more than 500 high-growth entrepreneurial enterprises, covering angel to B round and managing RMB and US dollar dual-currency funds. Our K2VC Foundation is dedicated to identifying and supporting future leaders in China's public welfare sector and has supported more than 70 public welfare organizations and social enterprises. With the mission of "Empowering the young people creating the future", we support and accompany outstanding entrepreneurs to climb the peak and devote to the great progress of business and technology.
-
vision+ Capital
- Investments: 248
- Funds: 8
- Hangzhou, Zhejiang Province
-
Low-carbon consumer goods
Vision Plus Capital was established by Eddie Wu, the co-founder of Alibaba, in 2015. As a venture capital firm with "industry + investment" origins, we concentrate on early-stage startups and engage in both RMB and USD investments, with a total management scale exceeding 10 billion yuan. Vision Plus Capital focuses on enterprise services, digital healthcare, cutting-edge technology, new consumption and cross-border trade. We have invested in more than 150 companies including Li Auto, Tuya, Tantan, AI Speech, MissFresh, Weimai, Fadada, Neoxbio, HHO, Huamaitaike, Smart Fabric, Zhuben, Jiepei and Yaoyanshe.